ibuprofen has been researched along with Systemic Inflammatory Response Syndrome in 3 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
Systemic Inflammatory Response Syndrome: A systemic inflammatory response to a variety of clinical insults, characterized by two or more of the following conditions: (1) fever
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tenorio-Laranga, J | 1 |
Montoliu, C | 1 |
Urios, A | 1 |
Hernandez-Rabaza, V | 1 |
Ahabrach, H | 1 |
García-Horsman, JA | 1 |
Felipo, V | 1 |
Kopp, MA | 1 |
Liebscher, T | 1 |
Watzlawick, R | 1 |
Martus, P | 1 |
Laufer, S | 1 |
Blex, C | 1 |
Schindler, R | 1 |
Jungehulsing, GJ | 1 |
Knüppel, S | 1 |
Kreutzträger, M | 1 |
Ekkernkamp, A | 1 |
Dirnagl, U | 1 |
Strittmatter, SM | 1 |
Niedeggen, A | 1 |
Schwab, JM | 1 |
Santos, AA | 1 |
Wilmore, DW | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Rho-Inhibitor Ibuprofen for the Treatment of Acute Spinal Cord Injury: Investigation of Safety, Feasibility and Pharmacokinetics[NCT02096913] | Phase 1 | 12 participants (Actual) | Interventional | 2013-06-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for ibuprofen and Systemic Inflammatory Response Syndrome
Article | Year |
---|---|
SCISSOR-Spinal Cord Injury Study on Small molecule-derived Rho inhibition: a clinical study protocol.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Gastrointestinal Hemorrhag | 2016 |
The systemic inflammatory response: perspective of human endotoxemia.
Topics: Body Temperature; Cytokines; Endotoxemia; Endotoxins; Escherichia coli Infections; Heart Rate; Human | 1996 |
1 other study available for ibuprofen and Systemic Inflammatory Response Syndrome
Article | Year |
---|---|
The expression levels of prolyl oligopeptidase responds not only to neuroinflammation but also to systemic inflammation upon liver failure in rat models and cirrhotic patients.
Topics: Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Cyclic GMP; Cytokines; Disease | 2015 |